Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Hans‐Henrik Parving
ResearcherPublications, citations & collaboration network
Hans‐Henrik Parving is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 142 works, 26,342 citations, an h-index of 61 and an i10-index of 109.
142
Works
26,342
Citations
61
h-index
109
i10-index
IDs:OpenAlex
How has Hans‐Henrik Parving's publication output changed over time?
ScholarIQpublication output · 1987–2016
Output grew0% over the shown period — from 1 works in 1987 to 1 in 2016.
1
1
1
1
1
1
3
1
1
1
1987199719992000200120032004200920102016
What are the most-cited papers on Hans‐Henrik Parving?
ScholarIQmost cited works
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw, William F. Keane, William E. Mitch, Hans‐Henrik Parving, Giuseppe Remuzzi, Steven Snapinn, Zhonxin Zhang, Shahnaz Shahinfar
New England Journal of Medicine. 20017,516 CitationsOPEN ACCESS
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
Peter Gæde, Pernille Vedel, Nicolai Balle Larsen, Gunnar V.H. Jensen, Hans‐Henrik Parving, Oluf Pedersen
New England Journal of Medicine. 20034,410 CitationsOPEN ACCESS
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Bengt Fellström, Alan G. Jardine, Roland E. Schmieder, Hallvard Holdaas, Kym M. Bannister, Jaap J. Beutler, Dong‐Wan Chae, Alejandro Chevaile, Stuart M. Cobbe, Carola Grönhagen‐Riska, José J. De Lima, R. Lins, Gert Mayer, Alan W. McMahon, Hans‐Henrik Parving, Giuseppe Remuzzi, Ola Samuelsson, S. Sonkodi, Gültekin Süleymanlar, Dimitrios Tsakiris, Vladimı́r Tesař, Vasil Todorov, Andrzej Więcek, Rudolf P. Wüthrich, Mattis Gottlow, Eva Johnsson, Faı̈ez Zannad
New England Journal of Medicine. 20092,033 CitationsOPEN ACCESS
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study
Peter Gæde, Pernille Vedel, Hans‐Henrik Parving, Oluf Pedersen
The Lancet. 1999996 Citations
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL
Dick de Zeeuw, Giuseppe Remuzzi, Hans‐Henrik Parving, William F. Keane, Zhongxin Zhang, Shahnaz Shahinfar, Steve Snapinn, Mark E. Cooper, William E. Mitch, Barry M. Brenner
Kidney International. 2004973 CitationsOPEN ACCESS
Related on ScholarIQ
University of Copenhagen
Institution
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
Paper
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
Paper
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Paper
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study
Paper
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL
Paper